Roche’s Vabysmo Grabs Top Growth Spot As Sales Decline

Retreats From MAGE-A4 Bispecifics

 
• By Ayisha Sharma
Blue eyes with eye lashes
Vabysmo Could Challenge Eylea and Lucentis With Label Expansions • Source: Shutterstock

More from Earnings

More from Business